Skip to main content

News

Explore the latest stories and publications from NCATS and our partners, see upcoming events, or explore the variety of resources we provide to better understand translational science and our work.

News

Read the latest news from NCATS and its collaborators whose research is supported through the Center’s programs, or follow coverage of NCATS' translational research activities through national and local media.

Working Together Is the Name of the Game at Rare Disease Day at NIH 2019

April 4, 2019 - NCATS News

Rare Disease Day at NIH, held on February 28, 2019, exemplifies NCATS’ approach to rare diseases research: involving patients as partners throughout the translational research process to ensure tha

Patients to Share Personal Journeys at NIH Rare Disease Day Events

February 11, 2019 - NCATS News

  • Genetic and Rare Diseases (GARD) Information Center

On February 28, 2019, Rare Disease Day at NIH will take place for public and private researchers, patients and their support organizations, policy makers and

New Method Could Help Find Potential Treatments for Rare Diseases

January 5, 2019 - NCATS News

  • Assay Development and Screening Technology (ADST)

Scientists in NCATS’ Assay Development and Screening Technology Program are developing new methods for screening small molecules that could help researchers test possible drugs and develop new trea

New Funding Opportunities Available for Collaborative Rare Diseases Research

June 11, 2018 - NCATS News

  • Rare Diseases Clinical Research Network (RDCRN)

NCATS has released two new funding opportunities to support collaborative clinical research on rare diseases through the Rare Diseases Clinical Research Network.

NIH Hosts Rare Disease Day Event on March 1, 2018

February 20, 2018 - NCATS News

  • Our Impact on Rare Diseases

Several thousand rare diseases affect an estimated 25 million people in the United States. Only a few hundred of these diseases have an approved treatment.

Gene Therapy for Rare, Pediatric Condition Moves Closer to Reaching U.S. Patients

September 6, 2017 - NCATS News

  • Therapeutics for Rare and Neglected Diseases (TRND)

Researchers from NCATS’ Therapeutics for Rare and Neglected Diseases program and Agilis Biotherapeutics, Inc., collaborated to bring a gene therapy for the rare pediatric condition aromatic L-amino

Last updated on February 19, 2025